Literature DB >> 12203789

A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.

Anja Wagner1, Heleen van der Klift, Patrick Franken, Juul Wijnen, Cor Breukel, Vladimir Bezrookove, Ron Smits, Yulia Kinarsky, Alicia Barrows, Barbara Franklin, Jane Lynch, Henry Lynch, Riccardo Fodde.   

Abstract

Genomic deletions of the MSH2 gene are a frequent cause of hereditary nonpolyposis colorectal cancer (HNPCC), a common hereditary predisposition to the development of tumors in several organs including the gastrointestinal and urinary tracts and endometrium. The mutation spectrum at the MSH2 gene is extremely heterogeneous because it includes nonsense and missense point mutations, small insertions and deletions leading to frameshifts, and larger genomic deletions, the latter representing approximately 25% of the total mutation burden. Here, we report the identification and molecular characterization of the first paracentric inversion of the MSH2 locus known to cause HNPCC. Southern blot analysis and inverse PCR showed that the centromeric and telomeric breakpoints of the paracentric inversion map within intron 7 and to a contig 10 Mb 3' of MSH2, respectively. Pathogenicity of the paracentric inversion was demonstrated by conversion analysis. The patient's lymphocytes were employed to generate somatic cell hybrids to analyze the expression of the inverted MSH2 allele in an Msh2-deficient rodent cellular background. The inversion was shown to abolish MSH2 expression by both northern and western analysis. This study confirms that Southern blot analysis still represents a useful and informative tool to screen for and identify complex genomic rearrangements in HNPCC. Moreover, monoallelic expression analysis represents an attractive approach to demonstrate pathogenicity of unusual mutations in autosomal dominant hereditary conditions. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203789     DOI: 10.1002/gcc.10094

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

1.  Inversion of exons 1-7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population.

Authors:  Jennifer Rhees; Mildred Arnold; C Richard Boland
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

2.  Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics.

Authors:  Monika Morak; Verena Steinke-Lange; Trisari Massdorf; Anna Benet-Pages; Melanie Locher; Andreas Laner; Katrin Kayser; Stefan Aretz; Elke Holinski-Feder
Journal:  Fam Cancer       Date:  2020-04       Impact factor: 2.375

Review 3.  Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.

Authors:  Henry T Lynch; Jane F Lynch; Patrick M Lynch; Thomas Attard
Journal:  Fam Cancer       Date:  2007-11-13       Impact factor: 2.375

Review 4.  Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Authors:  Henry T Lynch; Murray Joseph Casey; Carrie L Snyder; Chhanda Bewtra; Jane F Lynch; Matthew Butts; Andrew K Godwin
Journal:  Mol Oncol       Date:  2009-02-21       Impact factor: 6.603

Review 5.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.

Authors:  H T Lynch; P M Lynch; S J Lanspa; C L Snyder; J F Lynch; C R Boland
Journal:  Clin Genet       Date:  2009-07       Impact factor: 4.438

6.  Biallelic MUTYH mutations can mimic Lynch syndrome.

Authors:  Monika Morak; Barbara Heidenreich; Gisela Keller; Heather Hampel; Andreas Laner; Albert de la Chapelle; Elke Holinski-Feder
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

7.  Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

Authors:  Anja Wagner; Alicia Barrows; Juul Th Wijnen; Heleen van der Klift; Patrick F Franken; Paul Verkuijlen; Hidewaki Nakagawa; Marjan Geugien; Shantie Jaghmohan-Changur; Cor Breukel; Hanne Meijers-Heijboer; Hans Morreau; Marjo van Puijenbroek; John Burn; Stephany Coronel; Yulia Kinarski; Ross Okimoto; Patrice Watson; Jane F Lynch; Albert de la Chapelle; Henry T Lynch; Riccardo Fodde
Journal:  Am J Hum Genet       Date:  2003-03-25       Impact factor: 11.025

8.  Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.

Authors:  Holly L Harper; Jesse K McKenney; Brandie Heald; Andrew Stephenson; Steven C Campbell; Thomas Plesec; Cristina Magi-Galluzzi
Journal:  Mod Pathol       Date:  2016-10-07       Impact factor: 7.842

9.  Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH.

Authors:  Seyed Mohammad Akrami; Malcolm G Dunlop; Susan M Farrington; Ian M Frayling; Fiona MacDonald; John F Harvey; John A L Armour
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

10.  Germline and Tumor Sequencing as a Diagnostic Tool To Resolve Suspected Lynch Syndrome.

Authors:  Bernard J Pope; Mark Clendenning; Christophe Rosty; Khalid Mahmood; Peter Georgeson; Jihoon E Joo; Romy Walker; Ryan A Hutchinson; Harindra Jayasekara; Sharelle Joseland; Julia Como; Susan Preston; Amanda B Spurdle; Finlay A Macrae; Aung K Win; John L Hopper; Mark A Jenkins; Ingrid M Winship; Daniel D Buchanan
Journal:  J Mol Diagn       Date:  2020-12-29       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.